Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Recommendations for the evaluation and treatment of patients with diabetes and albuminuria. Role of non-steroidal mineralocorticoid antagonism Juan Payán López; Pedro Chinchurreta Capote; Antonio Hormigo Pozo; Luis Castilla-Guerra; José Carlos Fernández-García; Rosa Fernández Olmo; María José Espigares Huete;